Form4insider filings, from the source

SEC Form 4 · accession 0001106578-26-000114

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairperson & CEO · Director
Period of report
Aug 5, 2026
Accepted (ET)
Aug 6, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Aug 5, 2026M9,500$135.42A333,943Iby Trust
Common StockF3,F2Aug 5, 2026S200$502.29D333,743Iby Trust
Common StockF4,F2Aug 5, 2026S80$504.305D333,663Iby Trust
Common StockF5,F2Aug 5, 2026S160$507.2375D333,503Iby Trust
Common StockF6,F2Aug 5, 2026S160$510.2775D333,343Iby Trust
Common StockF2Aug 5, 2026S80$511.07D333,263Iby Trust
Common StockF7,F2Aug 5, 2026S529$514.2805D332,734Iby Trust
Common StockF8,F2Aug 5, 2026S205$515.4447D332,529Iby Trust
Common StockF9,F2Aug 5, 2026S386$516.7245D332,143Iby Trust
Common StockF10,F2Aug 5, 2026S557$517.4848D331,586Iby Trust
Common StockF11,F2Aug 5, 2026S1,891$518.5108D329,695Iby Trust
Common StockF12,F2Aug 5, 2026S1,496$519.6207D328,199Iby Trust
Common StockF13,F2Aug 5, 2026S1,011$520.5782D327,188Iby Trust
Common StockF14,F2Aug 5, 2026S1,385$521.6434D325,803Iby Trust
Common StockF15,F2Aug 5, 2026S939$522.6577D324,864Iby Trust
Common StockF16,F2Aug 5, 2026S261$523.8785D324,603Iby Trust
Common StockF17,F2Aug 5, 2026S160$524.59D324,443Iby Trust
Common Stockholding———40,513D
Common Stockholding———166Iby Spouse
Common StockF18holding———249,108Iby Trust
Common StockF19holding———45,596Iby Trust
Common StockF20holding———8,902Iby Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionF21$135.42Aug 5, 2026M9,500DMar 15, 2023Mar 15, 2027Common Stock9,500198,910I

Explanation of responses